Ironwood Pharmaceuticals (STU:I76) Other Net Income (Loss) : €-0.0 Mil (TTM As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Ironwood Pharmaceuticals Other Net Income (Loss)?

Ironwood Pharmaceuticals's Other Net Income (Loss) for the three months ended in Mar. 2024 was €0.0 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2024 was €-0.0 Mil.

Ironwood Pharmaceuticals's quarterly Other Net Income (Loss) increased from Sep. 2023 (€-0.0 Mil) to Dec. 2023 (€0.0 Mil) but then declined from Dec. 2023 (€0.0 Mil) to Mar. 2024 (€0.0 Mil).

Ironwood Pharmaceuticals's annual Other Net Income (Loss) increased from Dec. 2021 (€-0.0 Mil) to Dec. 2022 (€0.0 Mil) and increased from Dec. 2022 (€0.0 Mil) to Dec. 2023 (€0.0 Mil).

Ironwood Pharmaceuticals Other Net Income (Loss) Historical Data

The historical data trend for Ironwood Pharmaceuticals's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ironwood Pharmaceuticals Other Net Income (Loss) Chart

Ironwood Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Net Income (Loss)

Get a 7-Day Free Trial

-33.69

Ironwood Pharmaceuticals Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Net Income (Loss)	Get a 7-Day Free Trial															-	-	-	-	-

Ironwood Pharmaceuticals Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.0 Mil.

Ironwood Pharmaceuticals Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Ironwood Pharmaceuticals's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Ironwood Pharmaceuticals (STU:I76) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ironwood Pharmaceuticals Inc (STU:I76) » Definitions » Other Net Income (Loss)

Comparable Companies

Traded in Other Exchanges

IRWD:USA I76:Germany

Address

100 Summer Street, Suite 2300, Boston, MA, USA, 02110

Website

https://www.ironwoodpharma.com

Ironwood Pharmaceuticals is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing innovative product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Ironwood Pharmaceuticals (STU:I76) Headlines

No Headlines